Back
Results - Announcements
Sales rise 26.65% to Rs 38.21 crore
Trident Texofab reports standalone net profit of Rs 0.51 crore in the March 2025 quarter
30-May-2025, 05:54
Net profit of Trident Texofab reported to Rs 0.51 crore in the quarter ended March 2025 as against net loss of Rs 0.10 crore during the previous quarter ended March 2024. Sales rose 26.65% to Rs 38.21 crore in the quarter ended March 2025 as against Rs 30.17 crore during the previous quarter ended March 2024.
Net profit of Trident Texofab reported to Rs 0.51 crore in the quarter ended March 2025 as against net loss of Rs 0.10 crore during the previous quarter ended March 2024. Sales rose 26.65% to Rs 38.21 crore in the quarter ended March 2025 as against Rs 30.17 crore during the previous quarter ended March 2024.
For the full year,net profit rose 132.41% to Rs 2.51 crore in the year ended March 2025 as against Rs 1.08 crore during the previous year ended March 2024. Sales rose 22.70% to Rs 122.06 crore in the year ended March 2025 as against Rs 99.48 crore during the previous year ended March 2024.
Particulars | Quarter Ended | Year Ended | ||||
Mar. 2025 | Mar. 2024 | % Var. | Mar. 2025 | Mar. 2024 | % Var. | |
Sales | 38.21 | 30.17 | 27 | 122.06 | 99.48 | 23 |
OPM % | 3.53 | 3.38 | - | 4.49 | 6.19 | - |
PBDT | 0.84 | -0.07 | LP | 4.23 | 2.51 | 69 |
PBT | 0.43 | -0.48 | LP | 2.58 | 0.86 | 200 |
NP | 0.51 | -0.10 | LP | 2.51 | 1.08 | 132 |
Powered by Capital Market - Live News